Avastin bevacizumab regulatory update

The U.K.'s NICE issued an preliminary appraisal recommending against the use of Avastin bevacizumab from Roche in combination with a taxane for

Read the full 228 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE